Expeditors Announces Semi-Annual Cash Dividend of $0.81
Get Alerts EXPD Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1%
Revenue Growth %: +7.2%
Join SI Premium – FREE
BELLEVUE, Wash.--(BUSINESS WIRE)-- Expeditors International of Washington, Inc. (NYSE: EXPD) today announced that on May 4, 2026 its Board of Directors declared a semi-annual cash dividend of $0.81 per share, payable on June 15, 2026 to shareholders of record as of June 1, 2026.
“Since 2024, we have returned nearly $2 billion to shareholders in dividends and share repurchases,” said David A. Hackett, Senior Vice President and Chief Financial Officer. "In addition, in February of this year our Board authorized a new share repurchase program that permits the repurchase of up to $3 billion of our common stock. With our history of being a dividend aristocrat, combined with this 5% dividend increase and our new $3 billion share repurchase program, we demonstrate our commitment to returning substantial cash to our shareholders.”
About Expeditors International of Washington, Inc:
Expeditors is a global logistics company headquartered in Bellevue, Washington. The Company employs trained professionals in 171 district offices and numerous branch locations located on six continents linked into a seamless worldwide network through an integrated information management system. Services include the consolidation or forwarding of air and ocean freight, customs brokerage, vendor consolidation, cargo insurance, time-definite transportation, order management, warehousing and distribution and customized logistics solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260505927764/en/
Daniel R. Wall
President and Chief Executive Officer
(206) 674-3455
David A. Hackett
Senior Vice President and Chief Financial Officer
(206) 674-3400
Geoffrey Buscher
Director - Investor Relations
(206) 892-4510
Source: Expeditors International of Washington, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer
- Winamp Group Announces the Filing of a U.S. Lawsuit Against NVIDIA and a Major Development in the Belgian Proceedings
- Minnesota or The Moon: Pulsar Helium to Present Verified Helium-3 Discovery at Quantum Tech World 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Dividend, Stock Buyback, Dividend AristocratsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share